Assembly BIOSCIENCES, Inc. (ASMB) intrinsic value & 10-year financials
Assembly BIOSCIENCES, Inc. (ASMB) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 29.7% a year to $72.3M, with an average return on invested capital of -131.7%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $20.09
- Market cap
- $225.2M
- Revenue (FY2025)
- $72.3M
- Revenue growth (10-yr CAGR)
- 29.7%
- ROIC (10-yr avg)
- -131.7%
- Free cash flow (FY2025)
- -$41.2M
ASMB 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $72.3M | -$6.1M | -$0.55 | -$41.2M | -16.8% | -16.4% |
| FY2024 | $28.5M | -$40.2M | -$6.69 | -$51.1M | -159.3% | -453.7% |
| FY2023 | $7.2M | -$61.2M | -$13.38 | $22.5M | -902.5% | -245.2% |
| FY2022 | $0 | -$93.1M | -$1.92 | -$84.6M | — | -119.9% |
| FY2021 | $6.3M | -$129.9M | -$3.00 | -$96.5M | -2121.7% | -82.8% |
| FY2020 | $79.1M | -$62.2M | — | -$63.4M | -81.9% | -30.6% |
| FY2019 | $16.0M | -$97.6M | — | -$85.6M | -643.4% | -50.4% |
| FY2018 | $14.8M | -$90.8M | — | -$65.3M | -626.4% | -54.8% |
| FY2017 | $9.0M | -$42.8M | — | $995.5K | -579.1% | — |
| FY2016 | $0 | -$44.3M | — | -$35.0M | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ASSEMBLY BIOSCIENCES, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
ASSEMBLY BIOSCIENCES, INC. has historically struggled to out-earn its cost of capital, averaging just -45.2% ROIC.
ASSEMBLY BIOSCIENCES, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ASSEMBLY BIOSCIENCES, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-18.27 per share.